From: Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
 | Cortisol increase < 250 n M | Cortisol increase ≥ 250 n M | P | ||
---|---|---|---|---|---|
 | Etomidate | No etomidate | Etomidate | No etomidate | C, E, E*C |
 | n = 8 | n = 20 | n = 6 | n = 33 |  |
ACTH, pM | 2.8 (4.6) | 4.0 (11) | 1.1 (1.8) | 2.5 (2.6) | 0.02, 0.001, 0.27 |
Cholesterol, mM | 1.6 (1.5) | 1.6 (1.0) | 1.4 (0.7) | 2.5 (1.0) | 0.03, 0.06, 0.07 |
HDL-cholesterol, mM | 0.60 (0.30) | 0.40 (0.40) | 0.40 (0.50) | 0.90 (0.50) | 0.09, 0.13, 0.04 |
Progesterone, nM | 0.90 (1.5) | 0.70 (0.80) | 0.40 (0.70) | 0.60 (0.60) | 0.63, 0.83, 0.39 |
Corticosterone, nM | 2.6 (3.1) | 4.3 (8.0) | 6.0 (7.2) | 3.3 (6.5) | 0.71, 0.71, 0.06 |
Aldosterone, nM | 0.90 (1.2) | 0.90 (1.3) | 1.5 (1.3) | 1.0 (1.3) | 0.34, 0.95, 0.90 |
17-OH-progesterone, nM | 3.2 (2.3) | 2.5 (2.4) | 2.5 (3.2) | 2.6 (1.5) | 0.10, 0.16, 0.12 |
11ß-deoxycortisol, nM | 25 (56) | 2.8 (11) | 17 (45) | 2.0 (4.9) | 0.26, 0.05, 0.50 |
Cortisol, nM | 427 (192) | 518 (294) | 460 (230) | 460 (310) | 0.64, 0.70, 0.06 |
Cortisol/11ß-deoxycortisol | 13 (139) | 177 (400) | 38 (170) | 229 (372) | 0.15, < 0.001, 0.96 |
Cortisol/ACTH | 180 (120) | 107 (154) | 395 (376) | 165 (227) | < 0.001, < 0.001, 0.004 |
Cortisol increase, nM | 121 (114) | 180 (118) | 280 (30) | 440 (163) | na, < 0.001, na |
DHEA, μM | 6.4 (2.6) | 6.1 (5.6) | 5.5 (4.1) | 6.1 (3.9) | 0.88, 0.48, 0.80 |
DHEAS, nM | 1.0 (2.5) | 0.48 (1.1) | 0.55 (0.98) | 0.59 (0.90) | 0.55, 0.03, 0.16 |
Androstenedione, nM | 3.7 (8.7) | 2.9 (3.8) | 3.6 (5.6) | 2.2 (2.4) | 0.23, 0.93, 0.19 |